High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$51.3M
$51,327,628
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$75,317
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $75,317 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$210,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $210,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$39,904
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $39,904 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$165,541
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $165,541 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$163,040
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $163,040 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$49,915
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $49,915 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$48,041
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $48,041 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-05
$239,427
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-05 | $239,427 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $72,624 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $94,540 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $264,901 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $120,806 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $99,442 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $73,786 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $34,881 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $36,369 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$67,739
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $67,739 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$88,367
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $88,367 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$248,385
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $248,385 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$113,054
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $113,054 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$93,006
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $93,006 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$68,974
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $68,974 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$32,641
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $32,641 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$33,817
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $33,817 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$18,563
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $18,563 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$24,366
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $24,366 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$68,006
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $68,006 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$31,009
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $31,009 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$25,424
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $25,424 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$18,928
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $18,928 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$8,960
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $8,960 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$9,252
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $9,252 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $41,281 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $87,902 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $118,430 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $315,096 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $43,069 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $112,084 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $86,303 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$33,817
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $33,817 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $143,416 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$67,739
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $67,739 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$32,641
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $32,641 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$68,974
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $68,974 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$88,367
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $88,367 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$248,385
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $248,385 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$113,054
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $113,054 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-04
$93,006
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-04 | $93,006 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$148,854
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $148,854 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$205,107
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $205,107 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$101,142
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $101,142 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-03-03
$112,443
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-03-03 | $112,443 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$115,447
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $115,447 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$231,408
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $231,408 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$89,851
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $89,851 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$91,483
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $91,483 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$115,668
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $115,668 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$90,200
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $90,200 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$31,491
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $31,491 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$16,181
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $16,181 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $64,724 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$33,525
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $33,525 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$13,971
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $13,971 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $21,035 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $40,257 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $115,924 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $176,804 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $148,762 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $45,362 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $77,152 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $37,055 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $42,819 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $17,630 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$28,784
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $28,784 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$60,007
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $60,007 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$35,172
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $35,172 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-03-02
$137,587
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-03-02 | $137,587 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$12,308
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $12,308 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$31,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $31,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$26,799
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $26,799 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$56,051
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $56,051 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$32,871
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $32,871 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$107,803
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $107,803 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$128,110
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $128,110 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$84,013
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $84,013 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$29,218
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $29,218 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$15,210
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $15,210 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$12,308
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $12,308 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$31,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $31,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$26,799
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $26,799 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$56,051
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $56,051 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$32,871
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $32,871 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$107,803
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $107,803 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$128,110
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $128,110 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$84,013
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $84,013 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$29,218
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $29,218 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$15,210
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $15,210 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $53,222 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $132,440 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $114,474 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $238,051 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $139,373 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $458,410 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $545,446 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $357,542 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $124,016 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$41,773
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $41,773 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$747,119
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $747,119 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$384,197
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $384,197 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$46,815
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $46,815 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2026-02-27
$313,196
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2026-02-27 | $313,196 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-02-17
$677,532
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-02-17 | $677,532 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-02-13
$607,448
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-02-13 | $607,448 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-02-13
$695,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-02-13
$607,448
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-02-13 | $607,448 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2026-02-13
$2,157,542Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $2,157,542Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$104,420
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $104,420 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$45,668
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $45,668 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$72,401
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $72,401 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$238,280
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $238,280 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$207,243
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $207,243 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$180,051
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $180,051 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $13,351 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$13,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $13,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,917
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,917 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,600
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,600 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$34,288
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $34,288 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$44,056
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $44,056 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$30,527
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $30,527 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$55,834
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $55,834 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$35,422
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $35,422 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$26,454
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $26,454 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$17,087
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $17,087 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$72,601
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $72,601 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$80,423
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $80,423 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$18,320
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $18,320 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$15,063
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $15,063 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$33,913
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $33,913 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$7,047
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $7,047 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$745
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $745 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$5,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $5,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$7,137
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $7,137 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$5,667
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $5,667 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$13,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $13,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$14,917
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $14,917 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$14,600
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $14,600 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$34,288
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $34,288 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$44,056
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $44,056 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$30,527
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $30,527 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$55,834
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $55,834 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$35,422
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $35,422 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$26,454
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $26,454 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$17,087
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $17,087 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$72,601
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $72,601 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$80,423
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $80,423 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$18,320
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $18,320 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$15,063
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $15,063 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$33,913
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $33,913 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$14,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $14,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$7,047
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $7,047 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$745
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $745 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$5,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $5,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$7,137
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $7,137 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-01-12
$5,667
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-01-12 | $5,667 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $25,484 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,702 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,063 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $62,862 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $80,949 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $56,026 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $102,302 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $65,422 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $48,921 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $31,629 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $133,163 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $148,052 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $33,710 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $27,922 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $62,665 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $26,972 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $2,235 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $9,361 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $12,772 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $10,201 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $87,426 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $95,538 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $93,652 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $216,802 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $278,664 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $192,858 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $353,016 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $225,545 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $168,144 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $109,429 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $459,321 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $509,956 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $115,786 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $95,891 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $215,274 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $93,478 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $43,763 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $7,822 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $32,951 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $44,327 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $35,515 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$13,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $13,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,917
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,917 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,600
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,600 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$34,288
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $34,288 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$44,056
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $44,056 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$30,527
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $30,527 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$55,834
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $55,834 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$35,422
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $35,422 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$26,454
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $26,454 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$17,087
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $17,087 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$72,601
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $72,601 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$80,423
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $80,423 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$18,320
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $18,320 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$15,063
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $15,063 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$33,913
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $33,913 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$14,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $14,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$6,676
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $6,676 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$1,117
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $1,117 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$5,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $5,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$7,137
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $7,137 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2026-01-12
$5,667
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2026-01-12 | $5,667 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $199,920 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,950 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,988 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,898 | M | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$136,609
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $136,609 | S | Form 4 |
|
ALNY
M
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Other
2025-11-17
$972,220
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Other
|
2025-11-17 | $972,220 | M | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 SellΔOwn -24.5%
2025-11-17
$3,667,432Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 SellΔOwn -24.5%
|
2025-11-17 | $3,667,432Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$58,245
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $58,245 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$43,209
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $43,209 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$167,528
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $167,528 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$166,075
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $166,075 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$119,836
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $119,836 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$363,978
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $363,978 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$286,052
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $286,052 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$325,814
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $325,814 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$149,213
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $149,213 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $454,594 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $119,024 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $88,665 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $399,965 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $724,107 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $769,202 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $999,630 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $664,680 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $292,815 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-13 | $1,191,300Large | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-12 | $27,443 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-12 | $1,786,950Large | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $318,578 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $957,588 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $203,927 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $566,206 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $547,440 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $484,813 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $891,486 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-12
$1,551,637Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,551,637Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-12
$1,105,069Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,105,069Large | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $276,457 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $197,121 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$405,680
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $405,680 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$189,114
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $189,114 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$97,690
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $97,690 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$306,893
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $306,893 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
10b5-1 Sell
2025-10-03
$365,010
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
10b5-1 Sell
|
2025-10-03 | $365,010 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$1,373
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $1,373 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $1,831 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$33,275
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $33,275 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$110,981
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $110,981 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$149,290
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $149,290 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$302,397
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $302,397 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$150,018
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $150,018 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$243,888
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $243,888 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$111,998
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $111,998 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$80,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $80,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$25,084
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $25,084 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$51,351
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $51,351 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Garg Pushkal
• Officer • EVP Chief R&D
Sell to Cover
2025-10-02
$67,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP Chief R&D
Sell to Cover
|
2025-10-02 | $67,242 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $87,369 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $43,303 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $144,184 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $194,214 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $393,388 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $195,204 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $317,370 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $145,732 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $105,012 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $32,698 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $66,980 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $4,119 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $204,014 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $100,736 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $337,036 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $453,316 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $918,508 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $456,379 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $740,230 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $340,941 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $245,926 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $76,594 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $156,286 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$458
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $458 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$32,020
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $32,020 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$15,954
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $15,954 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$53,216
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $53,216 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$71,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $71,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$144,408
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $144,408 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$71,846
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $71,846 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$117,211
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $117,211 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$53,525
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $53,525 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$38,594
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $38,594 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$12,094
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $12,094 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2025-10-02
$24,559
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2025-10-02 | $24,559 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$1,373
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $1,373 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$55,806
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $55,806 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$27,349
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $27,349 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$92,333
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $92,333 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$123,879
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $123,879 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$251,243
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $251,243 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$124,713
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $124,713 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$202,414
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $202,414 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$93,107
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $93,107 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$67,316
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $67,316 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$21,052
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $21,052 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$42,867
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $42,867 | S | Form 4 |